Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study
暂无分享,去创建一个
T. Holtz | R. Grant | A. Varangrat | Tareerat Chemnasiri | Bonnie J Dye | A. Chitwarakorn | K. Amico
[1] T. Holtz,et al. Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] R. Grant,et al. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. , 2017, The lancet. HIV.
[3] T. Holtz,et al. Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006-13: an observational study. , 2015, The lancet. HIV.
[4] Moffat Joel Matyanga Celia. Pre-exposure Prophylaxis for HIV Prevention , 2014 .
[5] Megha L Mehrotra,et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.
[6] K. Amico,et al. Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] S. Karim,et al. Topical Microbicides—What's New? , 2013, Journal of acquired immune deficiency syndromes.
[8] T. Holtz,et al. HIV and Syphilis Infection Among Men Who Have Sex with Men — Bangkok, Thailand, 2005–2011 , 2013, MMWR. Morbidity and mortality weekly report.
[9] B. Gazzard,et al. Controlling the HIV Epidemic with Antiretrovirals , 2013, Journal of the International Association of Providers of AIDS Care.
[10] J. Baeten,et al. Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don’t We Know? , 2013, Current HIV/AIDS Reports.
[11] B. Friedland,et al. Microbicide clinical trial adherence: insights for introduction , 2013, Journal of the International AIDS Society.
[12] J. Baeten,et al. Oral antiretroviral chemoprophylaxis: current status , 2012, Current opinion in HIV and AIDS.
[13] K. Amico,et al. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness , 2012, Current opinion in HIV and AIDS.
[14] Peter L. Anderson,et al. Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.
[15] James D. Campbell,et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.
[16] Stefan D Baral,et al. Global epidemiology of HIV infection in men who have sex with men , 2012, The Lancet.
[17] H. Xi-ping,et al. HIV and syphilis infections among men who have sex with men , 2012 .
[18] C. Celum. HIV Preexposure Prophylaxis : New Data and Potential Use therapy , 2012 .
[19] David V Glidden,et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.
[20] Pai-Lien Chen,et al. Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial , 2008, Sexually transmitted diseases.
[21] K. Squires,et al. Once-daily antiretroviral therapies for HIV infection: Consensus statement of an Advisory Committee of the International Association of Physicians in AIDS Care , 2002, Journal of the International Association of Physicians in AIDS Care.